For decades, scientists searching for treatments for Alzheimer’s and Parkinson’s have focused on a deceptively simple goal: stop harmful proteins from clumping together in the brain. Those clumps—tangles of tau in Alzheimer’s disease and aggregates of alpha-synuclein in Parkinson’s—are linked to the loss of memory, movement, and independence that define these disorders.
But a new study published in Nature Communications suggests a subtler, potentially transformative strategy. Instead of trying to prevent proteins from misbehaving at all, researchers found that a small molecule naturally produced by the body, called spermine, may help cells neutralize toxic protein buildups by packaging them into forms the cell can safely dispose of.
While the study did not uncover a long-sought cure, it does offer a promising reframing: instead of trying to eliminate every misbehaving protein, help the cell package the problem into something its disposal systems can remove.
Proteins are the workhorses of cells, but they are also fragile. Each must fold into a precise shape to function. Misfolded proteins can stick to one another, disrupting cellular operations. To prevent this, cells rely on “quality control” pathways—systems that refold proteins, tag them for destruction, or recycle them.
One of the major recycling routes is autophagy, a process that encloses unwanted cellular material. In essence, it allows a cell to disassemble its junk parts, repurpose what is salvageable and discard what is not.
As we age, these clearance systems can become less effective, allowing abnormal protein structures to accumulate. In the brain, this is especially dangerous.
As people live longer, neurodegenerative disease associated with Aging—such as Alzheimer’s and Parkinson’s—are becoming more widespread.
The World Health Organization (WHO) estimates that 57 million people worldwide lived with dementia in 2021, with nearly 10 million new cases each year, and emphasizes dementia as a major cause of disability and dependency among older adults. Alzheimer’s disease is the most common cause of dementia, often estimated at 60–80% of cases.
Parkinson’s disease is also rising. WHO reports that the prevalence of Parkinson’s has doubled over the past 25 years, and that global estimates in 2019 showed over 8.5 million people living with Parkinson’s. A Global Burden of Disease 2021–based analysis published in Frontiers in Aging Neuroscience estimated 11.77 million people worldwide had Parkinson’s disease in 2021, and projected increases in burden in coming years.
The Nature Communications study focuses on an emerging idea in biology: proteins don’t just clump or stay separate—they can form temporary, droplet-like structures inside cells. These droplets, sometimes described as liquid compartments without walls, can help organize cellular activity. But if they harden or grow out of control, they may become toxic.
Spermine appears to influence this process.
Spermine is a small, positively charged molecule found in all human cells. It plays many roles, including helping cells respond to Stress. In this study, researchers showed that spermine changes how tau and alpha-synuclein proteins behave. Instead of forming rigid, harmful clumps, the proteins were more likely to assemble into softer, more organized bundles.
Why does that matter? Because cells are much better at cleaning up these softer structures. In simple terms, spermine doesn’t eliminate problem proteins. It packages them in a way the cell knows how to throw away.
This shift—from stopping protein buildup to managing it—could be crucial for diseases tied to aging.
Neurons are long-lived cells. They can’t easily be replaced, and once they are lost, symptoms worsen. That makes early intervention especially important. A treatment that helps neurons cope with stress, rather than trying to eliminate every faulty protein, may help preserve brain function longer.
The discovery also fits into a broader rethinking of Alzheimer’s and Parkinson’s. Instead of seeing them as purely caused by specific proteins gone wrong, scientists increasingly view them as failures of cellular maintenance—systems overwhelmed by decades of wear and tear.
This research does not suggest that people should take spermine supplements. Polyamines like spermine affect many processes in the body and altering them without precision could be risky.
Instead, scientists envision new drugs inspired by spermine, designed to gently steer harmful proteins into forms that cells can safely remove. Future treatments may combine such molecules with therapies that boost cellular recycling or deliver drugs more precisely to brain cells.
Rather than a single “cure,” the goal would be to slow disease progression, extending not only lifespan, but the years people can live independently.
FDA approves first blood test to help with Alzheimer’s diagnosis
Debunking 8 medical myths about dementia and Alzheimer’s disease
Can Viagra help to boost brain health and prevent Alzheimer’s disease?
A novel new treatment for Alzheimer’s? Xenon gas shows promise, leads to clinical trial
How your personality type may protect you from dementia
Social mobility extends years lived without dementia, Japanese study reveals
Researchers detect Parkinson’s markers up to 15 years before symptoms
Content on this site is for informational purposes only and is not a substitute for professional medical advice. Always check with your qualified healthcare providers with any questions or concerns regarding a medical condition.
